Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The return on invested capital (ROIC) is N/A as of Tuesday, October 6, 2026.
RETURN ON INVESTED CAPITAL (ROIC)
N/A
Freenome, Inc.
Market Cap
$134.75M
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$134.21M
Return on Invested Capital (ROIC)
-143.97%
TTM Avg
-52.39%
3Y Avg
-55.03%
5Y Avg
-91.26%
Market Cap
$133.80M
Return on Invested Capital (ROIC)
-314.66%
TTM Avg
-92.03%
3Y Avg
-77.08%
5Y Avg
-89.09%
Market Cap
$135.45M
Return on Invested Capital (ROIC)
-7.01%
TTM Avg
-1.96%
3Y Avg
-0.91%
5Y Avg
1.75%
Market Cap
$133.34M
Return on Invested Capital (ROIC)
-0.98%
TTM Avg
-12.17%
3Y Avg
-37.42%
5Y Avg
-26.70%
Market Cap
$133.19M
Return on Invested Capital (ROIC)
-21.42%
TTM Avg
-8.92%
3Y Avg
-14.86%
5Y Avg
-16.42%
Market Cap
$136.36M
Return on Invested Capital (ROIC)
-38.45%
TTM Avg
-32.47%
3Y Avg
-32.47%
5Y Avg
-32.47%
Market Cap
$136.66M
Return on Invested Capital (ROIC)
-7.95%
TTM Avg
-23.12%
3Y Avg
-29.64%
5Y Avg
-23.50%
Market Cap
$139.73M
Return on Invested Capital (ROIC)
-10.85%
TTM Avg
-101.00%
3Y Avg
-120.85%
5Y Avg
-96.47%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Freenome, Inc. (FRNM) | $134.75M | N/A | N/A | N/A | N/A |
| LifeMD, Inc. (LFMD)vs › | $134.21M | -143.97% | -52.39% | -55.03% | -91.26% |
| Pyxis Oncology, Inc. (PYXS)vs › | $133.80M | -314.66% | -92.03% | -77.08% | -89.09% |
| AirSculpt Technologies, Inc. (AIRS)vs › | $135.45M | -7.01% | -1.96% | -0.91% | 1.75% |
| Organigram Global Inc. (OGI)vs › | $133.34M | -0.98% | -12.17% | -37.42% | -26.70% |
| Health Catalyst, Inc. (HCAT)vs › | $133.19M | -21.42% | -8.92% | -14.86% | -16.42% |
| Atrium Therapeutics, Inc. (RNA)vs › | $136.36M | -38.45% | -32.47% | -32.47% | -32.47% |
| KORU Medical Systems, Inc. (KRMD)vs › | $136.66M | -7.95% | -23.12% | -29.64% | -23.50% |
| Fortress Biotech, Inc. (FBIOP)vs › | $139.73M | -10.85% | -101.00% | -120.85% | -96.47% |
| Alpha Cognition Inc (ACOG)vs › | $139.63M | -50.04% | -28.33% | -324.90% | -237.35% |
ROIC
N/A
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
